Picture of Geovax Labs logo

GOVX Geovax Labs Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Geovax Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.96-18.6-14-26-25
Depreciation
Non-Cash Items0.1890.4080.9021.070.529
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0016.93-5.97-0.356-0.307
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Cash from Operating Activities-2.75-11.2-19-25.2-24.7
Capital Expenditures-0.157-0.048-0.134-0.049-0.021
Purchase of Fixed Assets
Cash from Investing Activities-0.157-0.048-0.134-0.049-0.021
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities12.512.835.44.0623.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.61.5416.2-21.2-0.946